Longboard Pharmaceuticals Inc (LBPH)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
59.98 +0.02 (+0.03%) 11/29/24 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 59.98 unch (unch) -
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -54,422 | -43,945 | -27,797 | -14,400 | N/A |
| Depreciation Amortization | 5 | 5 | 1 | N/A | N/A |
| Accounts payable and accrued liabilities | -308 | 282 | -185 | 1,213 | N/A |
| Other Working Capital | 1,267 | 3,119 | 967 | 2,450 | N/A |
| Other Operating Activity | 2,590 | 2,476 | 2,309 | 7,295 | 0 |
| Operating Cash Flow | $-50,868 | $-38,063 | $-24,705 | $-3,442 | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 24,233 | -17,064 | -40,700 | N/A | N/A |
| PPE Investments | N/A | N/A | -16 | N/A | N/A |
| Investing Cash Flow | $24,233 | $-17,064 | $-40,716 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 32,277 | N/A | 84,774 | 3,200 | N/A |
| Other Financing Activity | -2,086 | -444 | -8,323 | 55,558 | 0 |
| Financing Cash Flow | $30,191 | $-444 | $76,451 | $58,758 | $N/A |
| Beginning Cash Position | 10,775 | 66,346 | 55,316 | N/A | N/A |
| End Cash Position | 14,331 | 10,775 | 66,346 | 55,316 | N/A |
| Net Cash Flow | $3,556 | $-55,571 | $11,030 | $55,316 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -50,868 | -38,063 | -24,705 | -3,442 | N/A |
| Capital Expenditure | N/A | N/A | -16 | N/A | N/A |
| Free Cash Flow | -50,868 | -38,063 | -24,721 | -3,442 | 0 |